Given that tumor BRAF V600E mutation has been widely advocated as a negative predictor for LS-associated CRCs [26]–[30], there is a high likelihood that these two cases are likely sporadic CRCs or arise from hypermethylation pathways. This evidence concerns the gene BRAF and neoplasm.